JBM (Healthcare) Limited

2161

KYG1090B1077

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:05 2024-05-31 am EDT			5-day change	1st Jan Change
0.93 ^HKD	-1.06%		-3.12%	-11.43%

May. 03	JBM to See 120% Increase in Fiscal 2024 Profit	MT
May. 03	Jbm Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended March 31, 2024	CI

JBM Limited Announces Change of Headquarters and Principal Place of Business in Hong Kong

September 09, 2022 at 05:18 am EDT

The board of directors of JBM (Healthcare) Limited announced that the address of headquarters and the principal place of business of the Company in Hong Kong will be changed to Units 808-811, 8th Floor, C-Bons International Centre, 108 Wai Yip Street, Kwun Tong, Kowloon, Hong Kong with effect from 21 September 2022. The telephone number, facsimile number and website of the Company remain unchanged.

Latest news about JBM (Healthcare) Limited

JBM to See 120% Increase in Fiscal 2024 Profit	May. 03	MT
Jbm Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended March 31, 2024	May. 03	CI
JBM Group Group Limited Announces Revision of the Existing Annual Caps for the Continuing Connected Transactions Under the 2023 Manufacturing Services Agreement	Apr. 02	CI
JBM Limited Announces Board Changes, Effective 9 March 2024	Mar. 08	CI
JBM Limited Announces Change of Company Secretary	Nov. 22	CI
JBM (Healthcare) Hikes Dividend as Six-Month Profit Soars 189%	Nov. 22	MT
JBM Limited Announces Interim Dividend for the Six Months Ended 30 September 2023, Payable on 28 December 2023	Nov. 22	CI
JBM Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 22	CI
JBM (Healthcare) Forecasts Threefold Jump in Fiscal H1 Profit	Nov. 07	MT
JBM Limited Provides Group Earnings Guidance for the Six Months Ended 30 September 2023	Nov. 07	CI
JBM Limited commences an Equity Buyback Plan for 91,368,600 shares, representing 10% of its issued share capital, under the authorization approved on August 1, 2023.	23-08-29	CI
JBM Limited Approves Final Cash Dividend for the Year Ended March 31, 2023	23-08-01	CI
JBM (Healthcare)'s FY23 Attributable Profit More Than Doubles	23-06-15	MT
JBM Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-15	CI
JBM Limited Proposes Final Dividend for the Financial Year End 31 March 2023, Payable on 01 September 2023	23-06-15	CI
JBM (Healthcare) Expects 130% Rise in FY23 Attributable Profit	23-05-31	MT
JBM Limited Provides Earnings Guidance for the Year Ended 31 March 2023	23-05-31	CI
JBM Limited completed the acquisition of remaining 50% stake in Five Ocean Inc. from Million Effort Investment Limited for HKD 19 million.	23-03-22	CI
JBM Healthcare to Take Full Ownership of Chinese Medicines JV	23-03-21	MT
JBM Group Limited agreed to acquire the remaining 50% stake in Five Ocean Inc. from Million Effort Investment Limited for HKD 17 million.	23-03-16	CI
JBM Healthcare's Profit for Six Months Through September Doubles	22-11-27	MT
JBM Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-25	CI
JBM Limited Declares Interim Dividend for the Six Months Ended 30 September 2022, Payable on 29 December 2022	22-11-25	CI
JBM (Healthcare) Expects Up to 120% Increase in April-September Profit; Shares Rally 12%	22-11-02	MT
JBM Limited Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Six Months Ended 30 September 2022	22-11-02	CI

Chart JBM (Healthcare) Limited

Duration

Period

More charts

Company Profile

JBM Healthcare Ltd is an investment holding company mainly engages in the marketing and distribution of proprietary Chinese medicines. The Company operates its business through three segments. The Proprietary Chinese Medicines segment mainly distributes over the counter (OTC) proprietary Chinese medicines and concentrated Chinese medicine granule (CCMG) products. The Consumer Healthcare Products segment primarily distributes proprietary medicines in the form of OTC. The Health and Wellness Products segment sales and distributes health and wellness products. The Company operates business in domestic and overseas markets such as Southeast Asia, Europe, and North America.

Sector

Pharmaceuticals

Calendar

2024-06-25 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
JBM (HEALTHCARE) LIMITED	-11.43%	98.47M
DONG-E-E-JIAO CO.,LTD.	+37.29%	6.02B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-21.28%	4.19B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+4.52%	3.25B
TASLY PHARMACEUTICAL GROUP CO., LTD	-18.16%	2.87B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-7.70%	2.37B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+41.50%	1.89B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-4.05%	1.58B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-15.56%	1.54B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-14.62%	1.5B

Alternative Medicine

JBM (Healthcare) Limited

Equities

2161

KYG1090B1077

Pharmaceuticals

JBM Limited Announces Change of Headquarters and Principal Place of Business in Hong Kong

Latest news about JBM (Healthcare) Limited

Chart JBM (Healthcare) Limited

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Alternative Medicine